INVESTing in improving HEALTHCARE

KICVentures is a healthcare growth & buyout investment holding company

KICVentures is the healthcare investment holding company for Kingsley Investment Company, founded in 2005 by ex-Arthur Andersen Management Consultant, Doctorpreneur, Dr. Kingsley R. Chin, a Harvard-trained, Orthopedic Spine Surgeon. We have raised over $30M and generated $235M in revenues and a sale to Stryker.

 
 

Mission

Provide investors with recurring returns possibilities leveraging our decades of expertise to buyout and grow profitable healthcare companies.

sectors

We are focused on 3 of the 5 key sectors of a healthcare system:

  1. Medical Devices

  2. Physician Services

  3. Digital Platforms

Investment Thesis

  1. Growth & buyout of healthcare companies

  2. Increase value over 5 times within 3-5 years

  3. Major acquisitions every 2 years

  4. Re-invest revenues + capital to execute long-term nimble strategies

KICV_WebsiteBanner.jpg

5 Key Sectors of a Healthcare System

 
 
 
 

LEADERSHIP

 
 
 
Spine Frontiers #1.jpg
 
KingsleyChin2019_v02.jpg

DR. KINGSLEY R. CHIN

Founder | CEO

  • Born in Jamaica.

  • Board Certified Orthopedic Spine Surgeon.

  • Columbia College, Columbia Engineering, Harvard Medical School (honors).

  • Former University of Pennsylvania Chief Orthopedic Spine Surgeon.

  • Business experience at AT&T Bell Labs and Arthur Andersen Management Consulting (Goldman Sachs and Cigna Insurance).

As a doctorpreneur, he brings 30 years of experience at the intersection of healthcare, entrepreneurship and business operations, including 13 years as Founder & CEO of Kingsley Investment Company (KIC) the parent company to KICVentures. Dr. Chin believes good companies become great when they have a winning quarterback, and that’s why he invests in continuous personal leadership development and finds ways to be uniquely competitive. As an example, he is an actively practicing board-certified orthopedic and spine surgeon because of the unique perspective it provides in:

  • Working directly with the medical devices in surgery

  • Working with surgeon colleagues and engineers to improve the devices

  • Working directly with all healthcare stakeholders, especially patients, to understand the market at every level

This 360 degree experience is a unique, game-changing advantage for making investment decisions, measuring the results and having the ability to nimbly make adjustments. Review his CV here

Dr. Chin is the author of the following books:

 
 

 
 
AdityaHumad_portrait_v01.jpg

ADITYA HUMAD

Co-Founder | CFO

Aditya Humad grew up in India and the Middle East. He graduated from the University of Pennsylvania at the Wharton School of Business and the School of Engineering where he met Dr. Kingsley R. Chin in 2003. His business experience started with J.P.Morgan on Wall Street in New York as a healthcare investment analyst focusing on healthcare M&A, capital raise and restructuring transactions before joining KICVentures in 2009. He has closed multiple M&A deals for KICVentures, most recently AxioMed and NanoFUSE Biologics. He brought focused financial oversight in raising over $30M in equity and debt capital for KICVentures. Review his CV here

 
 

 
KenYamada_BW.jpg

Ken Yamada

Chief Business Development Officer

  • 20+ years’ experience covering global medical markets

  • Formerly General Manager and Representative Director of Japan, Senior International Regional Manager of Asia Pacific for Arthrex, global leader in arthroscopy medical devices

  • Graduated from the University of Colorado Denver with an MBA in Finance and Master of Health Service Administration

Ken Yamada is Chief Business Development Officer for KICVentures, serving as a senior executive in a highly-regulated medical device (Orthopedics/Neurosurgery/Spine/Biologics/General Surgery) business covering global markets. He brings solid business practice ranging from strategic planning to tactical and operational execution. He has led the development-end of managing multi-million-dollar global businesses and operations. In addition, he has expertise in identifying markets and developing sales. He has opened new emerging markets, most recently in South East Asia in just 14 months. He has also had success in achieving sales targets by growing Asia over 30% and Latin America by 29%. Ken has developed distribution channels to support sales growth and market expansion and entry. He accomplishes his business objectives by building effective teams and customer advocates. Ken has an MBA and a Master of Science in Health Administration.  He has dual citizenship in the U.S. and Canada and is a permanent resident of Singapore, and speaks both Japanese and English. Review his CV here

 
 

JL_IMG_0723_BW.jpg

Jake Lubinski

Product Acquisition & Commercialization

  • 10+ years’ healthcare experience in operations, orthopedics product management, assembly line manufacturing process efficiency, and disc replacement

  • President of NanoFUSE Biologics

  • Formerly President of AxioMed and Chief Operating Officer of SpineFrontier, directed the acquisition & turnaround of AxioMed

  • M.S. in Mechanical Engineering with concentration in Biomechanics & Spine

 
 
 
 
 

MANAGEMENT TEAM

 
 
 
IMG_5263.JPG

key portfolio companies

 
AxioMed_logo.png

is a medical device company founded in 2001. It develops and manufactures proprietary viscoelastic spinal disc replacements. AxioMed raised +$75M from nine venture capital firms before KICVentures acquired the company in 2014. The Freedom Lumbar Disc U.S. clinical trials are completed with over 5 years of followup data. The Freedom Lumbar and Lateral Discs are awaiting FDA clearance, and the Freedom Cervical Disc U.S. clinical trials are pending. International commercialization is the next step. There is a high barrier to competition. Learn more at AxioMed.com.

 

 
NanoFUSE_logo.png

is a medical device company acquired in 2018. NanoFUSE is the only FDA-cleared combination of Synthetic Bioactive Glass and Organic Biologics (Demineralized Bone Matrix) in the world. There is a high barrier to competition. Learn more at NanoFUSEBiologics.com.

 

 
SpineFrontier_logo.png

Spinefrontier is is a medical device company founded in 2006. It develops and manufactures proprietary best-in-class spine implants and instruments for our trademarked Less Exposure Surgery (LESTM) techniques. It has been profitable since 2011. Learn more at SpineFrontier.com.

 

 
MediC_logo_sm.png

MediConnects is a digital health mobile platform. It creates a new social media platform in healthcare, imitating LinkedIn, Facebook and Instagram on behalf of medical information. The mission is to share medical experiences and knowledge for the world to reference, guide treatment and optimize the online patient experience through an easy and useable platform. Learn more at MediConnects.com.

 

 
LESSInstitute_logo.png

The LESS Institute is a physician services company founded in 2008 to treat patients with our trademarked Less Exposure Surgery (LES) techniques with a plan to build a professional surgeon group and specialty treatment centers of excellence. The LESS Institute is profitable and has begun its international expansion strategy in Jamaica. Learn more at TheLESSInstitute.com.

 

 

Investors

The spine industry has gone through a high growth phase and is now consolidating evidenced by multiple acquisitions [1]. We see consolidation and market expansion for the next 5 years as larger players respond to growth pressures and to new innovations in the areas of motion preservation and biologics. For more information on how you can invest in KICVentures provide your information below & we will be in touch.

Name *
Name